T regulatory cells and related immunoregulatory factors in polymorphic light eruption following ultraviolet A1 challenge

Br J Dermatol. 2013 Dec;169(6):1288-94. doi: 10.1111/bjd.12608.

Abstract

Background: Polymorphic light eruption (PLE) is considered to be an autoimmune-mediated skin condition in which the normal ultraviolet (UV)-induced local immunosuppression appears to be absent, leading to recognition of photoinduced autoantigens and subsequent inflammation.

Objectives: To investigate T regulatory cells (Tregs) and related immunoregulatory factors in PLE lesions and controls.

Methods: Skin biopsies were performed in 13 patients with UVA1-challenged PLE, 12 female patients with chronic discoid lupus erythematosus (CDLE) and 11 healthy controls who had exposure to UVA1. Immunohistochemistry and four-colour immunofluorescence studies were performed.

Results: Patients with CDLE and UVA1-exposed controls showed significantly decreased epidermal immunoreactivity for CD1a compared with patients with PLE (P = 0·0001). Four-colour immunofluorescence revealed a median percentage of CD4+CD25+FOXP3+ Tregs of 7·6% (range 3·7-13·6%) in PLE, a median of 11·7% (range 9·5-13·9%) in CDLE and a median of 3·4% (range 0-6·8%) in controls. Compared with UVA1-exposed controls, PLE and CDLE lesions showed significantly decreased transforming growth factor (TGF)-β1 immunoreactivity in the epidermis (P = 0·0003). In PLE lesions, we observed significantly decreased interleukin (IL)-10 expression compared with CDLE (P = 0·022). In the dermis, receptor activator of nuclear factor-κB ligand (RANKL) expression was increased in UVA1-exposed controls compared with PLE and CDLE (P = 0·018).

Conclusions: Similar to CDLE lesions, UVA1-challenged PLE lesions display an altered immunoregulatory network, as indicated by decreased epidermal or dermal expression of TGF-β1, IL-10 and RANKL, and a relatively low number of Tregs, particularly when compared with other inflammatory skin conditions reported in the literature.

MeSH terms

  • Adult
  • Case-Control Studies
  • Female
  • Fluorescent Antibody Technique
  • Humans
  • Immune Tolerance / immunology
  • Immunohistochemistry
  • Interleukin-10 / metabolism
  • Lupus Erythematosus, Discoid / immunology*
  • Photosensitivity Disorders / immunology*
  • RANK Ligand / metabolism
  • T-Lymphocytes, Regulatory / immunology*
  • Transforming Growth Factor beta1 / metabolism
  • Ultraviolet Rays*

Substances

  • RANK Ligand
  • Transforming Growth Factor beta1
  • Interleukin-10